Ocean Biomedical, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OCEA research report →
About the company
Ocean Biomedical, Inc. operates as a biopharmaceutical firm committed to identifying and advancing novel therapeutic solutions for various medical challenges, including cancer, fibrotic disorders, infectious illnesses, and inflammation. The company's pipeline includes the development of both mono-specific and bi-specific humanized monoclonal antibodies (mAbs).
- CEO
- Inderjote Kathuria
- IPO
- 2021
- Employees
- 7
- HQ
- Providence, RI, US
Price Chart
- Market Cap
- $23.24K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -1.20
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 8.38%
- ROIC
- 5.95%
- Revenue
- $0 · 0.00%
- Net Income
- $-3,301,000 · 0.00%
- EPS
- $-0.12 · 0.00%
- Op Income
- $-3,798,000
- FCF YoY
- 55.67%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.33
- Avg Volume
- 55.43K
Get TickerSpark's AI analysis on OCEA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 14, 23 | Poseidon Bio, LLC | other | 0 |
| Feb 14, 23 | Poseidon Bio, LLC | other | 18,582,930 |
Our OCEA coverage
Recent articles, reports, and earnings notes.
No research on OCEA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OCEA report →Similar companies
Peers in the same neighborhood.